NCT03509987View on ClinicalTrials.gov

The Evaluation of Point of Care Testing for Determining Hemoglobin Levels in Geriatric Intensive Care Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

April 1, 2018

Study Completion Date

April 5, 2018

Conditions
Point-of-Care Systems
Interventions
DEVICE

HemaCue

comparing hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.

Trial Locations (1)

06010

Mehtap Honca, Ankara

All Listed Sponsors
lead

Kecioren Education and Training Hospital

OTHER

NCT03509987 - The Evaluation of Point of Care Testing for Determining Hemoglobin Levels in Geriatric Intensive Care Patients | Biotech Hunter | Biotech Hunter